Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Meningioma 1

Interventions

Magnetic Resonance Spectroscopy 7lutetium Lu 177 dotatate 6Specimen Handling 5Bevacizumab 4gallium Ga 68 dotatate 3abemaciclib 3Radiosurgery 3Proton Therapy 3Nivolumab 3pembrolizumab 2Surveys and Questionnaires 2Sunitinib 2Protons 2Observation 2ONC206 2Ipilimumab 2Hydroxyurea 2Ga(III)-DOTATOC 2Everolimus 2Elasticity Imaging Techniques 2CTLA-4 Antigen 2tozuleristide 1ribociclib 1regorafenib 1olaparib 1neratinib 1dexamethasone acetate 1dexamethasone 21-phosphate 1capivasertib 1cabozantinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Meningioma × Lysine × 1 year × Clear all
NCT07150806 2026-05-22

RYZ101 for the Treatment of Progressive or Recurrent Intracranial Meningioma

Ohio State University Comprehensive Cancer Center

Phase 1/2 Recruiting
30 enrolled
CNS

Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡